Back
Akebia Therapeutics Stock Price Chart
Free 23-page book shares my #1 indicator to use
Here's the 23-page free book.
Sell
36
AKBA
Akebia Therapeutics
Last Price:
1.37
Seasonality Move:
-2.71%
7 Day Trial
ALL ACCESS PASS
$
7
10 minutes on Tuesday - $1,270 by Friday?
Click here to discover how this "odd" trade could double your money each week.- The current trend is moderately bearish and AKBA is experiencing slight buying pressure.
Akebia Therapeutics Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 1.4 | Sell |
| 20-day SMA: | 1.44 | Sell |
| 50-day SMA: | 1.39 | Sell |
| 200-day SMA: | 1.37 | Buy |
| 8-day EMA: | 1.39 | Sell |
| 20-day EMA: | 1.41 | Sell |
| 50-day EMA: | 1.36 | Buy |
| 200-day EMA: | 1.3 | Buy |
Akebia Therapeutics Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0 | Sell |
| Relative Strength Index (14 RSI): | 46.8 | Sell |
| Chaikin Money Flow: | 264579 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (1.39 - 1.51) | Sell |
| Bollinger Bands (100): | (1.07 - 1.43) | Buy |
Akebia Therapeutics Technical Analysis
| Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | Sep 19 | Sep 20 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | ||||||||||
| 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | 20 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Akebia Therapeutics Stock
Is Akebia Therapeutics Stock a Buy?
- Akebia Therapeutics share price is 1.37 while AKBA 8-day simple moving average is 1.40, which is a Sell signal.
- The stock price of AKBA is 1.37 while Akebia Therapeutics 20-day SMA is 1.44, which makes it a Sell.
- Akebia Therapeutics 50-day simple moving average is 1.39 while AKBA share price is 1.37, making it a Sell technically.
- AKBA stock price is 1.37 and Akebia Therapeutics 200-day simple moving average is 1.37, creating a Buy signal.
AKBA Technical Analysis vs Fundamental Analysis
Sell
36
Akebia Therapeutics (AKBA)
is a Sell
Is Akebia Therapeutics a Buy or a Sell?
-
Akebia Therapeutics stock is rated a Sell
The current Akebia Therapeutics [AKBA] share price is $1.37. The Score for AKBA is 36, which is 28% below its historic median score of 50, and infers higher risk than normal.
Akebia Therapeutics Stock Info
Market Cap:
288.09M
Price in USD:
1.37
Share Volume:
3.44M
Akebia Therapeutics 52-Week Range
52-Week High:
2.48
52-Week Low:
0.78
Sell
36
Akebia Therapeutics (AKBA)
is a Sell
Akebia Therapeutics Share Price Forecast
-
What is the Akebia Therapeutics stock price today?
The Akebia Therapeutics stock price is 1.37 USD today. -
Will AKBA stock go up or go down?
Akebia Therapeutics> share price is forecast to RISE/FALL based on technical indicators -
Is Akebia Therapeutics overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Akebia Therapeutics is overvalued.
Is Akebia Therapeutics Stock a Buy?
- Akebia Therapeutics share price is 1.37 while AKBA 8-day exponential moving average is 1.39, which is a Sell signal.
- The stock price of AKBA is 1.37 while Akebia Therapeutics 20-day EMA is 1.41, which makes it a Sell.
- Akebia Therapeutics 50-day exponential moving average is 1.36 while AKBA share price is 1.37, making it a Buy technically.
- AKBA stock price is 1.37 and Akebia Therapeutics 200-day simple moving average is 1.30, creating a Buy signal.
Fundamental Analysis of Akebia Therapeutics
Is Akebia Therapeutics a good investment?
- Analysts estimate an earnings increase this quarter of $0.04 per share, an increase next quarter of $0.01 per share, an increase this year of $0.14 per share, and an increase next year of $0.01 per share.
Technical Analysis of Akebia Therapeutics
Should I short Akebia Therapeutics stock?
- AKBA Moving Average Covergence Divergence (MACD) indicator is -0, suggesting Akebia Therapeutics is a Sell
- Akebia Therapeutics Relative Strength Index (RSI) is 46.8, which suggest Akebia Therapeutics is oversold
- The Bollinger Bands (25) for Akebia Therapeutics is (1.39 - 1.51), which suggest Akebia Therapeutics is a Buy
- The Bollinger Bands (100) for Akebia Therapeutics is (1.07 - 1.43), which suggest Akebia Therapeutics is a Buy
* Akebia Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.